Bosuvi 500 mg Tablet
$141.66
$124.66
Bosuvi 500 mg Tablet is a targeted anti-cancer treatment that features bosutinib as its key active ingredient, specifically designed to combat certain malignancies, including chronic myeloid leukemia (CML), a type of blood cancer characterized by the overproduction of white blood cells. This medication works by inhibiting specific proteins involved in cancer cell growth, ultimately helping to manage and control the progression of the disease. Patients using Bosuvi should be aware of potential side effects, including gastrointestinal issues and the risk of liver toxicity, making regular monitoring essential during treatment. It is crucial for individuals to discuss their medical history with a healthcare provider before starting this therapy to ensure it aligns with their overall treatment plan. Additionally, Bosuvi may interact with other medications, so informing your doctor about all current prescriptions is vital. With its innovative approach, Bosuvi offers hope for those battling CML, enhancing their quality of life through effective management of this challenging condition. Always follow your physician's guidance regarding dosage and usage to maximize the benefits of this medication while minimizing risks.
Quantity
Active Pharmaceutical Ingredient
Uses
• Bosuvi 500 mg tablet is primarily indicated for the treatment of chronic myeloid leukemia (CML). This condition arises from an overproduction of myeloid cells in the bone marrow, leading to various symptoms. Patients often experience fatigue and weakness due to the disease's impact on blood cell production. Bosuvi 500 mg tablet helps manage these symptoms by targeting the underlying mechanisms of CML.
• In cases of chronic myeloid leukemia, Bosuvi 500 mg tablet plays a critical role in inhibiting specific pathways that promote cancer cell growth. By blocking these pathways, the medication can help control the proliferation of malignant cells. This action is essential for improving patients' overall health and quality of life. Regular use of Bosuvi 500 mg tablet can lead to a reduction in disease symptoms and progression.
• Bosuvi 500 mg tablet is also beneficial for patients who have shown resistance to other treatments for chronic myeloid leukemia. It provides an alternative therapeutic option for individuals whose disease has not responded to standard therapies. By utilizing Bosuvi 500 mg tablet, healthcare providers can offer a tailored approach to manage CML more effectively. This can lead to improved outcomes and better disease management for patients.
• The effectiveness of Bosuvi 500 mg tablet in chronic myeloid leukemia makes it a vital part of treatment regimens. It is often prescribed in conjunction with other supportive measures to enhance patient care. Through consistent use, Bosuvi 500 mg tablet helps stabilize the disease and can lead to longer remission periods. This contributes significantly to the overall management strategy for individuals diagnosed with CML.
Benefits
Bosuvi 500 mg Tablet is used to treat a type of leukemia known as chronic myeloid leukemia (CML). It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of a protein called BCR-ABL that causes the overgrowth of cancerous cells and chronic myeloid leukemia. Bosuvi 500 mg can affect the bone marrow and blood cells. By inhibiting the activity of BCR-ABL, the Bosuvi Tablet for Leukemia can help reduce the number of cancer cells in the body and improve the symptoms associated with the disease.
Side Effects
Bosuvi 500 Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Pain in Stomach
• Blood in the stool or urine
• Chest pain
Common Side Effects
• Itching
• Hives
• Coloured Urine
• Abnormal liver function tests,
• Swelling
• Rash or
• Low blood cell counts.
How To Use
Bosutinib 500 mg Tablet may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Bosuvi 500 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Bosuvi 500 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Bosuvi Tablet for Leukemia should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Bosuvi Tablet for Leukemia. Bosuvi 500 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Bosuvi 500 Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Bosutinib Anti-Cancer Medicine should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bosutinib 500 mg Tablet and report any unusual symptoms or changes in liver function to their doctor. The dose of Bosuvi 500 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Bosutinib 500 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bosuvi 500 mg Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Use of Bosuvi 500 Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Bosuvi Tablet for Leukemia during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.